Apart from prevention using vaccinations, the management options for COVID-19 remain
limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor …

SARS-CoV-2 infection is required for COVID-19, but many signs and symptoms of COVID-19
differ from common acute viral diseases. SARS-CoV-2 infection is necessary but not …

Background Severe COVID-19 is characterized by pro-inflammatory cytokine release
syndrome (cytokine storm) which causes high morbidity and mortality. Recent observational …

Objective Reports that the over-the-counter histamine H 2 receptor antagonist famotidine
could help treat the novel coronavirus disease (COVID-19) appeared from April 2020. We …

The COVID-19 pandemic has driven great interest in the therapeutic potential of repurposed
drugs with well-established benefits and safety profiles (toxicity, bioavailability, etc.), many of …

The lack of coronavirus-specific antiviral drugs has instigated multiple drug repurposing
studies to redirect previously approved medicines for the treatment of SARS-CoV-2, the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes coronavirus
disease (COVID-19) is one of the most serious global health crises in recent history. COVID …

Introduction Famotidine is a competitive histamine H2-receptor antagonist most commonly
used for gastric acid suppression but thought to have potential efficacy in treating patients …

Background Famotidine was reported to potentially provide benefits to Coronavirus Disease
2019 (COVID-19) patients. However, it remains controversial whether it is effective in …

To the Editor: Coronavirus disease 2019 (COVID-19) is globe-trotting, and thousands of
researchers and stakeholders are spending reposeless days and sleepless nights in search …